TransCanna Holdings Inc. (CSE: TCAN) (XETR: TH8) (“TransCanna” or the “Company”) is pleased to announce that Mr. Peter Vitulli has joined the Board of Directors. Mr. Vitulli is currently an operating advisor at Windrose Health Investors and has extensive experience managing start-up enterprises for various investor groups. Earlier in his career Peter was President & General Manager of the $1 billion North American Gatorade business. Mr. Vitulli has over 35 years of experience in the consumer products and healthcare industries with both large corporations and entrepreneurial start-ups. He most recently served as President and CEO of DNA Diagnostics Center, one of the world’s largest providers of private DNA tests.
“I have a long-standing relationship with Peter and look forward to having him on our board. His related experience growing companies and specifically in the medical diagnostic area will help fast track critical decisions to build out our management team and introduce new products.” stated Steve Giblin, TransCanna, President and CEO.
Additionally, Mr. Vitulli served as President and CEO of Sciona, Inc., a pioneering personal genetics company offering customized health and wellness solutions and as President and CEO for Amerifit Nutrition, Inc., a nutritional supplement company focused on women’s health. He holds an MBA from New York University’s Stern School of Business and a BA from Holy Cross College.
“I am really looking forward to joining the TransCanna team. The company is superbly positioned in an exciting market and I believe my business and healthcare experience will help TransCanna aggressively grow to become one of the premier companies in the industry” stated Peter Vitulli.
Mr. Vitulli replaces Mr. Jim Pakulis as director, the company would like to thank Mr. Pakulis for his time with the company and wishes him well in his future endeavors.
About TransCanna Holdings Inc.
TransCanna Holdings Inc. is a Canadian based company providing branding, transportation and distribution services, through its wholly-owned California subsidiaries, to a range of industries including the cannabis marketplace.
For further information, please visit the Company’s website at www.transcanna.com or email the Company at info@transcanna.com.
On behalf of the Board of Directors,
Steve Giblin
President
604-609-6199
The information in this news release includes certain information and statements about management’s view of future events, expectations, plans and prospects that constitute forward looking statements. These statements are based upon assumptions that are subject to significant risks and uncertainties. Because of these risks and uncertainties and as a result of a variety of factors, the actual results, expectations, achievements or performance may differ materially from those anticipated and indicated by these forward-looking statements. Any number of factors could cause actual results to differ materially from these forward-looking statements as well as future results. Although the Company believes that the expectations reflected in forward looking statements are reasonable, it can give no assurances that the expectations of any forward-looking statements will prove to be correct. Except as required by law, the Company disclaims any intention and assumes no obligation to update or revise any forward-looking statements to reflect actual results, whether as a result of new information, future events, changes in assumptions, changes in factors affecting such forward-looking statements or otherwise.
Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/47848